Karyopharm Therapeutics Inc. (KPTI) vs Sintx Technologies, Inc. (SINT)
A side-by-side comparison of Karyopharm Therapeutics Inc. and Sintx Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KPTI
Karyopharm Therapeutics Inc.
$0.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SINT
Sintx Technologies, Inc.
$2.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — KPTI vs SINT
growth of $100 · dividends reinvested · last 10yKPTI -88.4% (-19.4%/yr)SINT -100.0% (-77.5%/yr)KPTI compounded faster over this window
Log scale — wide-divergence pair
KPTI SINT
KPTI vs SINT: by the numbers
- •KPTI is the larger company ($15M vs $14M market cap).
- •Both run net losses; KPTI's is the smaller (-153.28% vs -1303.40% net margin).
- •SINT grew revenue faster over the past five years (29.18% vs 7.47% CAGR).
Metrics side by side
Valuation
| Metric | KPTI | SINT |
|---|---|---|
| P/S ratio | 0.10 | 10.04 |
| P/B ratio | N/A | 2.87 |
Profitability
| Metric | KPTI | SINT |
|---|---|---|
| Gross margin | 95.88% | -19.74% |
| Operating margin | -56.17% | -1053.14% |
| Net margin | -153.28% | -1303.40% |
| ROE | N/A | -372.67% |
| ROIC | N/A | -157.90% |
Growth (annualized)
| Metric | KPTI | SINT |
|---|---|---|
| Revenue CAGR (5Y) | 7.47% | 29.18% |
| Total return CAGR (5Y) | -62.18% | N/A |
Frequently asked
- Which has grown faster, KPTI or SINT?
- Over the past five years, SINT grew revenue faster — KPTI at a 7.47% CAGR versus SINT at 29.18%.
Go deeper
Dig into the metrics
Karyopharm Therapeutics ROESintx Technologies ROEKaryopharm Therapeutics operating marginSintx Technologies operating marginKaryopharm Therapeutics revenue growthSintx Technologies revenue growthKaryopharm Therapeutics free cash flowSintx Technologies free cash flow
Karyopharm Therapeutics & Sintx Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.